At the March 6th meeting of MassMEDIC, the association of the medical device industry, two expert panels discussed both the key attributes which an early stage company must have to attract financing, and the landscape for obtaining that financing. Requisite … Continue reading
Stephen Honig
Chris Coburn, who runs the Partners Healthcare Innovation Center, delivered what amounted to a sales pitch to emerging life science companies, urging them to work with the vast Partners system. Addressing a meeting of MassMEDIC, the association of the medical … Continue reading
What is the pedestrian supposed to do when the entrance to that pedestrian’s office building is festooned with signs that say “Beware of Falling Ice”? Speaking of our snow here in Boston: if you save the parking space you dug … Continue reading
Corporate directors generally are aware of the fact that they are protected by the so-called “business judgment rule”: if a director of reasonable intelligence applies reasonable diligence and doesn’t make a personal profit out of any decisions, then courts … Continue reading
The so-called SDX Protocol, a roadmap prepared by directors, advisors and institutional investors to establish a play book for interaction between the investment community and independent corporate directors, was analyzed at the January 13 meeting of the National Association of … Continue reading
Did you ever get a thirst for an adult beverage during a snow storm, only to find your larder bare? Along comes Drizly, an application that can get your alcohol delivered to you, at least if you are in a … Continue reading
Proxy access, permitting shareholders to nominate directors and have that nomination included in the public company proxy statement itself, remains a volatile issue. You may recall that the SEC’s original regulation to provide shareholder access had two prongs: the first … Continue reading
During the time between year-end and the annual meeting, public boards are planning director elections, effecting audit review to conclude the annual financials, addressing 10K and proxy matters, evaluating shareholder proxy and other proposals from activists, and conducting intensified committee … Continue reading
If ever there was a company which tracks the history of start-ups from the late ‘90s to date, it is Bullhorn. Their highs and lows (they are a software solution for recruiting employees) were traced by Art Papas, CEO and … Continue reading
What are the trends in funding early stage life science companies? A panel of seven investors speculated on the 2015 outlook, at a December 10th Venture Summit held in Dedham yesterday. Riding an increasingly robust funding of transactions at the … Continue reading